113 related articles for article (PubMed ID: 8938353)
21. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
22. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.
Tsai HY; Hsi BL; Hung IJ; Yang CP; Lin JN; Chen JC; Tsai SF; Huang SF
Hum Pathol; 2004 Nov; 35(11):1397-403. PubMed ID: 15668898
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis in a neuroblastoma and hepatocyte coculture model.
Chen MK; Strande L; Kain M; Whalen TV; Doolin EJ
J Surg Res; 1998 Aug; 78(2):123-30. PubMed ID: 9733629
[TBL] [Abstract][Full Text] [Related]
24. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Poulaki V; Mitsiades N; Romero ME; Tsokos M
Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
[TBL] [Abstract][Full Text] [Related]
25. Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.
Dole MG; Clarke MF; Holman P; Benedict M; Lu J; Jasty R; Eipers P; Thompson CB; Rode C; Bloch C; Nuñez ; Castle VP
Cancer Res; 1996 Dec; 56(24):5734-40. PubMed ID: 8971184
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.
Tanaka S; Tajiri T; Noguchi S; Shono K; Ihara K; Hara T; Suita S
J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373
[TBL] [Abstract][Full Text] [Related]
27. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
Ariyoshi N
J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
[TBL] [Abstract][Full Text] [Related]
28. Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis.
Wang JX; Zheng S
Chin Med J (Engl); 2004 Dec; 117(12):1821-4. PubMed ID: 15603711
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression.
Ijiri R; Tanaka Y; Kato K; Misugi K; Nishihira H; Toyoda Y; Kigasawa H; Nishi T; Takeuchi M; Aida N; Momoi T
Am J Surg Pathol; 2000 Jun; 24(6):807-15. PubMed ID: 10843282
[TBL] [Abstract][Full Text] [Related]
30. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
31. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
32. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.
Nakagawara A; Nakamura Y; Ikeda H; Hiwasa T; Kuida K; Su MS; Zhao H; Cnaan A; Sakiyama S
Cancer Res; 1997 Oct; 57(20):4578-84. PubMed ID: 9377572
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan.
Tajiri T; Suita S; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Handa N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M;
Cancer; 2001 Jul; 92(2):349-53. PubMed ID: 11466689
[TBL] [Abstract][Full Text] [Related]
35. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
Ushmorov A; Hogarty MD; Liu X; Knauss H; Debatin KM; Beltinger C
Oncogene; 2008 May; 27(24):3424-34. PubMed ID: 18193081
[TBL] [Abstract][Full Text] [Related]
36. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma.
Mejía C; Navarro S; Colamonici OR; Pellín A; Castel V; Llombart-Bosch A
Oncol Rep; 1999; 6(1):149-53. PubMed ID: 9864419
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of the Bcl-2 family of proteins in end stage heart failure.
Latif N; Khan MA; Birks E; O'Farrell A; Westbrook J; Dunn MJ; Yacoub MH
J Am Coll Cardiol; 2000 Jun; 35(7):1769-77. PubMed ID: 10841223
[TBL] [Abstract][Full Text] [Related]
38. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
[TBL] [Abstract][Full Text] [Related]
39. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
